Both in Surgical Instruments
Bioventus vs Beta Bionics
Over the past year BVS returned +66.8% and BBNX returned −45.5%; their daily moves had a correlation of 0.15.
BVS +66.8% BBNX −45.5%Growth of $1, one year, split-adjusted
| Metric | BVS | BBNX |
|---|---|---|
| Price | $10.95 | $15.10 |
| Market cap | $747.6M | $820.9M |
| Today | −16.77% | −5.03% |
| 1 month | −19.0% | −20.3% |
| 6 months | +2.5% | +50.8% |
| Year to date | +47.1% | −50.4% |
| 1 year | +67.1% | −44.5% |
| Revenue growth (YoY) | +2.7% | +30.3% |
| Gross margin | 68.2% | 57.3% |
| Net margin | 4.2% | −68.6% |
| P/E (TTM) | 12.4× | — |
| Price / sales | 1.3× | 6.5× |
| Net cash | -$199.1M | $240.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.8% | 79.5% |
| Short % of float | 6.9% | 24.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).